Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Ototoxicity
- Sodium Thiosulfate Otoprotection During Salvage Cisplatin Therapy
- Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
- SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease
- Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children With Average-Risk Medulloblastoma and Reduced Therapy in Children With Medulloblastoma With Low-Risk Features
- Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy
- Evaluation of the Effect of Rosuvastatin on Cisplatin-induced Nephrotoxicity and Ototoxicity
- Sodium Thiosulfate for the Prevention of Ototoxicity in Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Undergoing Chemoradiation With Cisplatin
- Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.
- Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
- Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity
- Treatment of Radiation and Cisplatin Induced Toxicities With Tempol
- Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer
- SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
- Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin
- Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity
- Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
- SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
- Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment
- Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.
- Protective Effect of N-acetylcysteine Against From Ototoxicity
- The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans
- Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine
- Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
- Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy
- Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer
- Protection From Cisplatin Ototoxicity by Lactated Ringers
- Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
- Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin